ロード中...
Randomised double-blind trial of recombinant interferon-beta for condyloma acuminatum.
OBJECTIVE: To evaluate the safety and efficacy of two intralesional doses of recombinant human interferon-beta (r-hIFN-beta: Rebif, Ares Serono), given 3 times a week for 3 weeks, in the treatment of condyloma acuminatum. DESIGN: A randomised, double-blind, within-patient, placebo-controlled study....
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1996
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1195619/ https://ncbi.nlm.nih.gov/pubmed/8698357 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|